🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Trying to find a #biosensor for your studies, or recently publish a biosensor and want to share? Check out our biosensor database, where you can search for biosensors and submit newly published biosensors! biosensordb.ucsd.edu

Great summary of “The epic battle with cancer's 'Death Star'” by the Guardian featuring ⁦Channing Der⁩ ⁦Der Lab at UNC⁩ ⁦Kevan Shokat⁩ and many more. #killRAS #cancerbiology #KRAS theguardian.com/science/2021/m…

Finally secured the first NIH/NCI R01 HwangLab , with a bonus, R37 conversion. Feels grateful for all the support from my department and colleagues Biological Sciences UC Davis Comprehensive Cancer Cent. Now hiring a postdoc!

Nach der #AstraZeneca-Freigabe und einer #maiLab-Nachtschicht hier alles, was man jetzt wissen muss: youtu.be/oBLQmE-nG60

Very excited that our 5-year work is out today! Real-time drug response measurements in #organoids with single-cell resolution. nature.com/articles/s4155… Fantastic work by Bas Ponsioen and thanks to our great collaborators. #KRAS #SingleCell #colorectal #cancer

Excited to share our Der Lab at UNC #CancerResearch identifying BCAR1/p130Cas and TUBB3/betaIII-tubulin as #KRAS-mutant #PancreaticCancer therapeutic vulnerabilities and #MYC regulators. Thank you American Cancer Society ACS Research for support! #KillKRAS cell.com/cell-reports/f…

How it started vs. how it's going... From the Channing Der #postdoc room UNC Lineberger to our own #cancerresearch careers. Bryant Lab UNC Bjoern Papke #killkras KRASKickers #RASSymposium22

Glad that this North West Cancer Research funded work by Fiona Hood, Yasmina and Roz is finally out in Oncogene Journal. Ras abundance in ~90 cell lines and tissues. Challenges ideas explaining KRAS mutation frequency in cancer. Inst of Systems, Molecular & Integrative Biology

👇🏻👇🏻👇🏻not to be missed!

An #OpenAccess review on current status of KRAS inhibitors, resistance drivers & potential combinations from Der Lab at UNC Channing Der Bjoern Papke & colleagues DKFZ Charité - Universitätsmedizin Berlin in Trends in Cancer As always very informative illustrations: A: Frequency of KRAS Allelic alterations across

KRAS inhibitors: resistance drivers and combinatorial strategies: Trends in Cancer cell.com/trends/cancer/…

🚨 Thrilled to share our latest featured review with Tamara, Channing Der, and C. Sers: "KRAS Inhibitors: Resistance Drivers and Combinatorial Strategies" now #OpenAccess in @TrendsCancer! 🔬 authors.elsevier.com/sd/article/S24… Please read it and don’t forget to cite, cite, cite! 😉

KRAS inhibitors: resistance drivers and combinatorial strategies: Trends in Cancer cell.com/trends/cancer/…

Excited to share our latest in Nature Medicine✨ We present a detailed clinico-genomic landscape of pancreatic adenocarcinomas With important implications for RAS 🎯 therapies Expertly co-led by Anna Varghese and Maria A Perry. w/Eileen M O’Reilly & colleagues Memorial Sloan Kettering Cancer Center

We’re thrilled to announce the launch of Center for RAS Therapeutics to target the RAS oncogene in cancer. The first of its kind Center aims to advance new treatment approaches for patients with RAS mutant cancers. Learn more: bit.ly/3BobmtB

Top 4 things to know about doing science: 1. You need to have someone you can talk to 2. One-on-one discussions are the best 3. Think about discussions as improvisations and use the ‘yes, and’ rule 4. Create a safe space so both of you feel open to saying seemingly silly things

(1/4) 🚀 We are thrilled to announce the 2nd Targeting RAS Symposium! 🎯 Join us Oct 8-10, 2025, at Palacio de Congresos, Salamanca, Spain. AmbrogioLab Esther Castellano Sánchez Matthias Drosten Santamaria’s Lab Miriam Molina Arcas